Back to today’s briefing

Story perspectives

Spain Launches €15.6M Gene Therapy for Hemophilia B

6/18/2025

50 10

Summary

Story summary

Galicia's President Alfonso Rueda unveiled a groundbreaking €15.6 million investment in Etranacogene Dezaparvovec, Spain's first gene therapy for hemophilia B. This transformative initiative targets eight patients out of 51 diagnosed in the region, promising a brighter future as a 13-year study shows a remarkable reduction in bleeding episodes and infusion needs for those affected.

1 of 1

Story summary

Galicia's President Alfonso Rueda unveiled a groundbreaking €15.6 million investment in Etranacogene Dezaparvovec, Spain's first gene therapy for hemophilia B. This transformative initiative targets eight patients out of 51 diagnosed in the region, promising a brighter future as a 13-year study shows a remarkable reduction in bleeding episodes and infusion needs for those affected.